Biomarker detection in 3D cell models using automated immunofluorescence staining
23 Feb 2022
Physiologically relevant 3D cell models are essential for drug discovery and pre-clinical research due to their functional and architectural similarity to solid tumors. One of the challenges faced by researchers is that many of the assays using these precious samples tend to be manual and tedious.
Using proprietary microfluidics technology, Protein Fluidics has created the Pu·MA System for automated complex 3D cell-based assays. In this webinar, application scientist Dr. Katya Nikolov will present her work on combining this novel automation technology with Yokogawa’s high-content imaging systems for biomarker detection in 3D cell models. Nikolov will demonstrate the utility of an automated immunofluorescence staining workflow followed by confocal imaging within the Pu·MA System flowchips. This automated workflow enables quantitative assessment of biomarkers which provides valuable data for further understanding disease mechanisms, preclinical drug efficacy studies, and in personalized medicine.
Attendees of this webinar will explore:
Yokogawa Fluid Imaging Technologies, Inc
- The Pu·MA System and novel technology for automated 3D cell-based assays
- How to perform automated immunofluorescence staining for biomarkers with a “hands-off” assay workflow
- How to visualize biomarkers after the assay with high-content imaging within the flowchip